Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia, Moderate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03520998
What this trial is testing

Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMild to Moderate Alzheimer Disease
Alkahest, Inc. 47
Large-scale testing (Phase 3)Study completedNCT00566501
What this trial is testing

Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Inc. 915
Not applicableStudy completedNCT04325204
What this trial is testing

Faith-Based Toolbox for African Americans With Dementia

Who this might be right for
Alzheimer DiseaseDementia
Emory University 54
Testing effectiveness (Phase 2)Study completedNCT00948909
What this trial is testing

Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 274
Post-approval studies (Phase 4)Study completedNCT00800709
What this trial is testing

Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shanghai Mental Health Center 26
Testing effectiveness (Phase 2)Ended earlyNCT00500500
What this trial is testing

Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ipsen 40
Not applicableUnknownNCT04828434
What this trial is testing

Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study

Who this might be right for
DementiaDementia, VascularDementia, Mixed+8 more
University College, London 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06840054
What this trial is testing

The Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Tabriz University of Medical Sciences 30
Large-scale testing (Phase 3)Ended earlyNCT04886063
What this trial is testing

Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
LeonaBio 423
Large-scale testing (Phase 3)Ended earlyNCT00667810
What this trial is testing

Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients

Who this might be right for
Alzheimer Disease
Pfizer 901
Testing effectiveness (Phase 2)Looking for participantsNCT07367815
What this trial is testing

Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease

Who this might be right for
Alzheimer Disease
University Hospital, Toulouse 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04639050
What this trial is testing

Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 241
Not applicableNot Yet RecruitingNCT05575271
What this trial is testing

Implantable Vagus Nerve Stimulation Modulation of Coeruleus-Norepinephrine Network for Mild-Moderate AD Patients

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 6
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT02907567
What this trial is testing

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Cognition Therapeutics 19
Testing effectiveness (Phase 2)Study completedNCT05811442
What this trial is testing

Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Beijing Joekai Biotechnology LLC 68
Not applicableStudy completedNCT01089582
What this trial is testing

Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets

Who this might be right for
Alzheimer Disease
Pfizer 628
Large-scale testing (Phase 3)Study completedNCT00231946
What this trial is testing

ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)

Who this might be right for
Alzheimer's Disease
Voyager Pharmaceutical Corporation 555
Large-scale testing (Phase 3)Study completedNCT01021696
What this trial is testing

Pain in Patients With Dementia and Behavioural Disturbances

Who this might be right for
DementiaPainAgitation
University of Bergen 352
Early research (Phase 1)Study completedNCT01837641
What this trial is testing

LY3002813 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 63
Next Page